Cytopathology and More | FNA cytology: Rapid on-site evaluation—how practice varies

Create PDF

1. Silverman JF, Finley JL, O’Brien KF, et al. Diagnostic accuracy and role of immediate interpretation of fine needle aspiration biopsy specimens from various sites. Acta Cytol. 1989;33:791–796.
2. Gupta PK, Baloch ZW. Intraoperative and on-site cytopathology consultation: utilization, limitations, and value. Semin Diagn Pathol. 2002;19:227–236.
3. Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol. 2002;27:1–4.
4. Davenport R. Rapid on-site evaluation of transbronchial aspirates. Chest. 1990;98:59–61.
5. Shannon JJ, Bude RO, Orens JB, et al. Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy. Am J Respir Crit Care Med. 1996;153:1424–1430.
6. Fassina A, Corradin M, Zardo D, et al. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology. 2011;22:306–312.
7. Baloch ZW, Tam D, Langer J, et al. Ultrasound-guided fine-needle aspiration biopsy of the thyroid: role of on-site assessment and multiple cytologic preparations. Diagn Cytopathol. 2000;23:425–429.
8. Ghofrani M, Beckman D, Rimm DL. The value of onsite adequacy assessment of thyroid fine-needle aspirations is a function of operator experience. Cancer. 2006;108:110–113.
9. Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid. 2006;16:55–60.
10. Witt BL, Schmidt RL. Rapid onsite evaluation improves the adequacy of fine-needle aspiration for thyroid lesions: a systematic review and meta-analysis. Thyroid. 2013;23:428–435.
11. Collins BT, Murad FM, Wang JF, Bernadt CT. Rapid on-site evaluation for endoscopic ultrasound-guided fine-needle biopsy of the pancreas decreases the incidence of repeat biopsy procedures. Cancer Cytopathol. 2013;121:518–524.
12. van Rijk MC, Deurloo EE, Nieweg OE, et al. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol. 2006;13:31–35.
13. van Rijk MC, Teertstra HJ, Peterse JL, et al. Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol. 2006;13:1511–1516.
14. Silverman JF, Gurley AM, Holbrook CT, Joshi VV. Pediatric fine-needle aspiration biopsy. Am J Clin Pathol. 1991;95:653–659.
15. Anne S, Teot LA, Mandell DL. Fine needle aspiration biopsy: role in diagnosis of pediatric head and neck masses. Int J Pediatr Otorhinolaryngol. 2008;72:1547–1553.
16. Collins BT, Chen AC, Wang JF, Bernadt CT, Sanati S. Improved laboratory resource utilization and patient care with the use of rapid on-site evaluation for endobronchial ultrasound fine-needle aspiration biopsy. Cancer Cytopathol. 2013;121:544–551.
17. Schmidt RL, Walker BS, Howard K, Layfield LJ, Adler DG. Rapid on-site evaluation reduces needle passes in endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesions: a risk-benefit analysis. Dig Dis Sci. 2013;58:3280–3286.
18. Schmidt RL, Witt BL, Matynia AP, Barraza G, Layfield LJ, Adler DG. Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci. 2013;58:872–882.
19. Klevesath MB, Godwin RJ, Bannon R, et al. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur J Surg Oncol. 2005;31:490–494.
20. Silverman JF, Frable WJ. The use of the Diff-Quik stain in the immediate interpretation of fine-needle aspiration biopsies. Diagn Cytopathol. 1990;6:366–369.
21. Yang GC, Alvarez, II. Ultrafast Papanicolaou stain. An alternative preparation for fine needle aspiration cytology. Acta Cytol. 1995;39:55–60.
22. Sakuma T, Mimura A, Tanigawa N, et al. Rapid on-site cytologic examination of 1500 breast lesions using the modified Shorr’s stain [published online ahead of print June 4, 2013]. Breast Cancer.
23. Thierry R, Marie-Christine R, Mariele M, Richard B, Anca M. Modified technique of toluidine blue staining in rapid on-site evaluation. Diagn Cytopathol. 2012;40:847–848.
24. Burlingame OO, Kesse KO, Silverman SG, Cibas ES. On-site adequacy evaluations performed by cytotechnologists: correlation with final interpretations of 5241 image-guided fine-needle aspiration biopsies. Cancer Cytopathol. 2012;120:177–184.
25. Stelow EB. Who should perform rapid or on-site assessment of thyroid fine-needle aspirations? Am J Clin Pathol. 2012;138:8–9.
26. Savoy AD, Raimondo M, Woodward TA, et al. Can endosonographers evaluate on-site cytologic adequacy? A comparison with cytotechnologists. Gastrointest Endosc. 2007;65:953–957.
27. Hikichi T, Irisawa A, Bhutani MS, et al. Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists. J Gastroenterol. 2009;44:322–328.
28. Renshaw AA. 88172 is more than counting cells: ensuring the quality of immediate assessment of fine-needle aspiration material. Am J Clin Pathol. 2012;138:27–28.
29. Marotti JD, Johncox V, Ng D, Gonzalez JL, Padmanabhan V. Implementation of telecytology for immediate assessment of endoscopic ultrasound-guided fine-needle aspirations compared to conventional on-site evaluation: analysis of 240 consecutive cases. Acta Cytol. 2012;56:548–553.
30. Khurana KK, Kovalovsky A, Masrani D. Feasibility of telecytopathology for rapid preliminary diagnosis of ultrasound-guided fine needle aspiration of axillary lymph nodes in a remote breast care center. J Pathol Inform. 2012;3:36.
31. Pantanowitz L, Wiley CA, Demetris A, et al. Experience with multimodality telepathology at the University of Pittsburgh Medical Center. J Pathol Inform. 2012;3:45.
32. Mehrotra S, Barkan GA, Wafai RM, et al. Rapid on-site evaluation (ROSE)—is it affordable to provide this service? Mod Pathol. 2014; 27(suppl 2):112A–113A.

Drs. Tambouret, Barkan, Kurtycz, and Padmanabhan are members of the CAP Cytopathology Committee. Dr. Tambouret is a pathologist, Massachusetts General Hospital, and assistant professor of pathology, Harvard Medical School. Dr. Barkan is director of cytopathology and associate professor of pathology and urology, Department of Pathology, Loyola University Medical Center, Maywood, Ill. Dr. Kurtycz is laboratory medical director, Wisconsin State Laboratory of Hygiene, and professor, Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health. Dr. Padmanabhan is associate professor of pathology and director of cytology, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine. The authors thank Joseph Misdraji, MD, of Massachusetts General Hospital, for his input.